TCR² Therapeutics Hires Key Business Development and Regulatory Affairs Cell Therapy Experts to Support Strategic Objectives

    NEXT STORY
    Corbus Pharmaceuticals Reports Last Subject Visit in RESOLVE-1 Phase 3 Study of Lenabasum for Treatment of Systemic Sclerosis
    PREV STORY
    Inovalon Launches InfectionWatch™ For The Provider Marketplace
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    AB Science announces that results from masitinib study AB07015 in severe asthma have been selected for presentation at an ATS symposium held on 16th October, 2020

    author_avatar
    NASDAQ Market News

    FDA approves Roche’s Tecentriq in combination with Avastin for people with the most common form of liver cancer

    author_avatar
    NASDAQ Market News

    Autoimmune Disease Diagnostics Market Is Projected To Be Around $15.11 Billion By 2022

    LAS VEGAS, Oct. 25, 2017 (GLOBE NEWSWIRE) -- In 2012, the global Autoimmune Disease ...

    author_avatar
    NASDAQ Market News